Sign in
Abstract A123: Hallmarks of pharmacodynamic activity of CDR404, a new antibody-derived T cell engager (TCE) targeted against MAGE-A4+ solid tumors in HLA-A02:01+ patients
Abstract   Peer reviewed

Abstract A123: Hallmarks of pharmacodynamic activity of CDR404, a new antibody-derived T cell engager (TCE) targeted against MAGE-A4+ solid tumors in HLA-A02:01+ patients

Melissa Vrohlings, Matteo Morotti, Daniel Lenherr-Frey, Nikolina Vachtsevanou, Clare Price, Leonardo Borras, Rouven Bingel-Erlenmeyer, Paul Swiecicki, Coral Olazagasti, Rom Leidner, …
Molecular cancer therapeutics, Vol.24(10_Supplement), pp.A123-A123
2025-10-22

Metrics

1 Record Views

Details

Logo image